Total Payments
$19,793
2024 Payments
$4,951
Companies
22
Transactions
375
Medicare Patients
169
Medicare Billing
$17,828
Payment Breakdown by Category
Other$11,460 (57.9%)
Food & Beverage$7,898 (39.9%)
Gifts$200.00 (1.0%)
Travel$135.99 (0.7%)
Education$99.00 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,460 | 14 | 57.9% |
| Food and Beverage | $7,898 | 356 | 39.9% |
| Gift | $200.00 | 1 | 1.0% |
| Travel and Lodging | $135.99 | 3 | 0.7% |
| Education | $99.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $14,996 | 162 | $0 (2024) |
| Gilead Sciences, Inc. | $1,826 | 57 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,191 | 82 | $0 (2024) |
| Janssen Biotech, Inc. | $363.32 | 17 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $292.77 | 16 | $0 (2023) |
| Intra-Sana Laboratories | $233.40 | 3 | $0 (2023) |
| Ardelyx, Inc. | $160.14 | 4 | $0 (2024) |
| PFIZER INC. | $122.17 | 7 | $0 (2024) |
| IBSA Pharma Inc. | $116.67 | 1 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $97.27 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,951 | 93 | ABBVIE INC. ($3,770) |
| 2023 | $6,112 | 101 | ABBVIE INC. ($4,783) |
| 2022 | $4,827 | 87 | ABBVIE INC. ($3,513) |
| 2021 | $3,902 | 94 | AbbVie Inc. ($2,930) |
All Payment Transactions
375 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | LINZESS (Drug) | Travel and Lodging | In-kind items and services | $43.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.86 | General |
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.09 | General |
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GI COLON PREP | ||||||
| 10/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $115.99 | General |
| Category: HCV | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 85 | 100 | $20,259 | $9,573 |
| 2022 | 3 | 73 | 81 | $14,822 | $7,431 |
| 2021 | 1 | 11 | 12 | $1,612 | $823.91 |
Total Patients
169
Total Services
193
Medicare Billing
$17,828
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 43 | $8,888 | $4,185 | 47.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,547 | $3,049 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 33 | $4,824 | $2,339 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 39 | $8,045 | $3,946 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 24 | $3,509 | $1,792 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,269 | $1,693 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $1,612 | $823.91 | 51.1% |
About Meiting Liang
Meiting Liang is a Medical healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1396094587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meiting Liang has received a total of $19,793 in payments from pharmaceutical and medical device companies, with $4,951 received in 2024. These payments were reported across 375 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,460).
As a Medicare-enrolled provider, Liang has provided services to 169 Medicare beneficiaries, totaling 193 services with total Medicare billing of $17,828. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location New York, NY
- Active Since 09/03/2012
- Last Updated 09/03/2012
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1396094587
Products in Payments
- LINZESS (Drug) $12,506
- XIFAXAN (Drug) $975.53
- RINVOQ (Biological) $872.58
- CREON (Drug) $670.47
- Vemlidy (Drug) $468.06
- Epclusa (Drug) $365.99
- ZENPEP (Drug) $351.34
- STELARA (Biological) $305.80
- MAVYRET (Drug) $290.24
- SKYRIZI (Biological) $278.28
- HUMIRA (Biological) $270.38
- RELTONE 200 MG (Drug) $233.40
- TRULANCE (Drug) $215.10
- IBSRELA (Drug) $160.14
- Livdelzi (Drug) $125.00
- XELJANZ (Drug) $122.17
- Licart (Drug) $116.67
- VIBERZI (Drug) $108.14
- OCALIVA (Drug) $97.27
- TREMFYA (Drug) $57.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in New York
Michele Kissous-Hunt, Pa, PA
Medical — Payments: $242,198
Medical $242,198
Laura Maroldo, Rpa-C, RPA-C
Medical — Payments: $113,742
Medical $113,742
Helen Adams, Pa-C, PA-C
Medical — Payments: $67,599
Medical $67,599
Hailey Brickman, Pa-C, PA-C
Medical — Payments: $40,927
Medical $40,927
Maria Baldo, Pa, PA
Medical — Payments: $34,901
Medical $34,901
Michael Querijero, Rpa-C, RPA-C
Medical — Payments: $32,014
Medical $32,014